Emerging markets in Asia-Pacific and Latin America offer untapped potential due to rising healthcare infrastructure and supportive regulatory frameworks. Companies can capitalize on market growth strategies by developing next-generation vectors with enhanced safety, targeting capabilities, and scalable manufacturing processes to address unmet medical needs. https://www.patreon.com/posts/lentiviral-is-to-129517285?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link